The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
----------
JD Sports Fashion PLC - Manchester, England-based sportswear retailer - Successfully completes its £100 million share buyback programme, announced in September and managed by Peel Hunt LLP.
----------
Hochschild Mining PLC - London-based gold and silver miner in Argentina, Brazil and Peru - Confirms that Tiernan Gold Corp, previously a wholly-owned indirect subsidiary, has completed its qualifying transaction. As a result, trading in Tiernan’s common shares is expected to commence on the TSX Venture Exchange on or about Friday. Tiernan is focused on advancing the large-scale open-pit heap leach Volcan gold project located in the Maricunga region of Chile. Hochschild has received C$16.5 million following the sale of a part of its holding in Tiernan, which was completed concurrently with the recent brokered private placement. Consequently, Hochschild now has a 70% shareholding in Tiernan.
----------
Symphony Environmental Technologies PLC - Hertfordshire, England-based biodegradable plastic technology developer - Announces that as a result of management-driven strategic change in its Middle East operation, revenue for 2025 is now expected to be £5.4 million, with a comparable adjusted loss before interest, tax, depreciation and amortisation of £0.9 million. Company says it has successfully commenced its new manufacturing agreement with Pure Polymers in Jeddah, Saudi Arabia, a ‘key pillar’ of the strategic expansion in the Middle East. Manufacturing operations in Dubai have ceased, reflecting the focus on Saudi Arabia. While Middle East volumes in the second half of 2025 are expected to be nearly 70% lower than the year prior, volumes are expected to exceed 2024 levels going forward in 2026. Confident that the strategic shift to Saudi Arabia, combined with the new collaboration agreement and strengthened management and sales team leaves Symphony well placed to benefit from the expected sharp increase in demand in 2026.
----------
Kodal Minerals PLC - West Africa-focused mineral explorer and developer receives $21.3 million from offtake partner Hainan Mining Co Ltd for its maiden export of spodumene concentrate from the Bougouni project in southern Mali, marking first revenue. The company says processing restarts this week following maintenance, with the DMS plant expected to reach nameplate capacity, while mining and stockpiling continue and a second shipment is planned for the first quarter of 2026. CEO Bernard Aylward says: ‘Following the successful transport and shipment of the first export of spodumene concentrate, the Bougouni mining operation has continued with the build-up of the ROM stockpile ahead of the full recommencement of production, which should ensure that the DMS processing plant is able to produce approximately 10,000 tonnes per month.’
----------
Character Group PLC - Surrey, England-based toys, games and giftware company which manufactures Peppa Pig toys - Swings to pretax loss of £1.8 million in the 12 months to August 31 from profit of £5.7 million a year prior. Revenue drops to £100.5 million from £123.4 million with basic loss per share of 6.74 pence versus EPS of 25.96p a year ago. Calls 2025 a ‘difficult year’ and notes the imposition of tariffs on imports to the US severely impacted second half performance. Explains that the US accounted for 20% of turnover in the prior financial year and, with most of the group’s production sourced from China, says sales to the US immediately stalled and remained weak for the rest of the financial year. Declares a reduced final dividend of 3.0p per share, down from 11.0p, taking the total payout to 6.0p, down from 19.0p. Dividend covers falls to 0.9 times from 1.56 times. Sales in the lead up to Christmas 2025 have been slow and have declined from the comparable period in 2024 and adds the landscape in all the group’s markets is still looking ‘unsettled’, ‘We expect that conditions are likely to remain challenging for the rest of the first half of this financial year,’ it says. While turnover is likely to remain flat for the current financial year, the board expects profit (before tax and highlighted items) to more than double from £1.2 million in 2025.
----------
Frontier IP Group - London-based intellectual property commercialisation firm - Raises £695,000 via a placing and £175,000 via a subscription at 15.5 pence per share. A total £870,000. Singer Capital Markets acted as sole bookrunner and sole broker in connection with the placing. In addition, plans to raise £174,117 via a retail offer on the RetailBook Platform.
----------
MTI Wireless Edge Ltd - Rosh Haayin, Israel-based maker of antennas for military and commercial use - Announces that it has achieved AS9100D certification, the internationally recognised quality management standard for the aerospace and defence industries. Leading international defence companies and government organisations typically require AS9100D certification from their suppliers. With this certification now in place, MTI is better positioned to tender for high-value contracts across the sector as it continues to grow. ‘I believe we are now well placed to compete for new and potentially larger defence contracts,’ says Moni Borovitz, chief executive officer.
----------
Essentra PLC - Oxford, England-based manufacturer of plastic and metal hardware components - Announces the acquisition of Device Technologies LLC, a family-owned, US-based designer, manufacturer and distributor of specialty cable protection devices for an initial $6.7 million cash. Deferred consideration of $1.2 million may become due. Chief Executive Scott Fawcett says: ‘We are pleased to welcome another high-quality business, with a strong track record of growth into the Essentra Group, which will be accretive to both earnings and margins and support our strategy for long-term sustainable value creation.’ Essentra says the acquisition is ‘fully aligned’ with the group’s disciplined approach to inorganic growth, both in terms of strategic alignment and in delivering financial returns. Device Technologies is expected to deliver attractive revenue synergies through cross-selling opportunities into EMEA and APAC where Device Technologies today has limited presence. In 2024, Device Technologies generated revenues of $6.5 million. A return on invested capital of 15% is anticipated within three years, in keeping with the group’s acquisition criteria, Essentra adds.
----------
Netcall PLC - Bedford, England-based customer engagement software provider - At Wednesday’s annual general meeting Chair Henrik Bang says: ‘We are pleased to confirm that positive momentum has continued in the first half of FY26, and trading is in line with management’s expectations. Demand for our Liberty cloud platform is increasing as organisations move to unified automation, AI and customer engagement platforms that modernise operations and reduce complexity. This is driving ACV growth and supporting recurring revenue visibility.’ Adds: ‘New business remains healthy across our core sectors, with new‑logo sign‑ups at rates above last year and continuing growth from existing customers through cross‑sales and migrations.’ ‘With a strong pipeline, robust balance sheet and clear momentum from increased cloud and automation sales, we remain confident of continued progress in FY26,’ Bang says.
----------
Predator Oil & Gas Holdings PLC - Morocco and Trinidad-focused oil and gas company - Says 27,175 barrels of oil produced year to date with gross revenues of $806,051. Fully-funded for up to 12 infill development wells and 14 heavy workovers in 2026. Forecasts up to 1,000 bopd and 5- to 10-fold increase in monthly revenues by end-2026.
----------
N4 Pharma PLC - Derbyshire, England-based pharmaceutical company focused on Nuvec gene delivery system - Says the collaboration with the Centre for Continuous Manufacturing and Advanced Crystallisation based at the University of Strathclyde, is progressing well. The programme remains on track towards key in vitro and in vivo studies planned for the first half of 2026, and to build out the commercial data to demonstrate Nuvec’s key benefits and advance Nuvec towards clinical readiness. In addition, the company expects a strong flow of data-driven news in the coming months, including: further comparative performance data for Nuvec versus lipid nanoparticles; in vivo biodistribution and further targeting data; repeat of N4 101 in vivo study using two siRNA to reduce inflammation; and identification of assets that N4 Pharma will look to develop itself into clinical trials.
----------
By Jeremy Cutler, Alliance News reporter
Copyright 2025 Alliance News Ltd. All Rights Reserved.
